Compare BDL & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDL | WGRX |
|---|---|---|
| Founded | 1959 | 2022 |
| Country | United States | United States |
| Employees | 1990 | N/A |
| Industry | Restaurants | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.2M | 60.2M |
| IPO Year | N/A | 2025 |
| Metric | BDL | WGRX |
|---|---|---|
| Price | $31.05 | $0.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 616.0 | ★ 997.7K |
| Earning Date | 12-26-2025 | 11-19-2025 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | ★ 41.91 | N/A |
| EPS | ★ 2.32 | N/A |
| Revenue | ★ $201,851,000.00 | $34,077,635.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.31 | ★ N/A |
| Revenue Growth | 8.84 | ★ 495.93 |
| 52 Week Low | $22.61 | $0.34 |
| 52 Week High | $35.98 | $7.04 |
| Indicator | BDL | WGRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.37 | 47.60 |
| Support Level | $28.61 | $0.52 |
| Resistance Level | $30.01 | $0.64 |
| Average True Range (ATR) | 0.42 | 0.06 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 66.92 | 45.34 |
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.